phospho-ERK1/2 (Thr202 + Tyr204) Recombinant Antibody
Applications
Reactivity
| Overview | |
| Catalog # | bsm-34302r |
| Product Name | phospho-ERK1/2 (Thr202 + Tyr204) Recombinant Antibody |
| Applications | Flow-Cyt, ICC/IF |
| Reactivity | Human, Mouse, Rat |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Rabbit |
| Source | KLH conjugated Synthesised phosphopeptide derived from mouse p44/42 MAPK around the phosphorylation site of Thr202/Tyr204 |
| Clonality | Recombinant |
| Isotype | IgG |
| Concentration | 1mg/ml |
| Purification | Purified by Protein A. |
| Storage Buffer | 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target | |
| Gene ID | 5595 |
| Swiss Prot | E9PQW4 |
| Subcellular location | Nucleus |
| Synonyms | ERK1(phospho T202+Y204); p-ERK1(phospho T202+Y204); Erk1(pT202/pY204)+Erk2(pT185/pY187); p-ERK1/2(T202/Y204); ERK 1; ERK 2; MK03_HUMAN; MK01_HUMAN; ERK-2; ERK1; ERK2; ERT1; ERT2; Extracellular signal regulated kinase 1; Extracellular signal regulated kinase 1; Extracellular signal regulated kinase 2; Extracellular signal regulated kinase 2; Extracellular signal-regulated kinase 2; HS44KDAP; HUMKER1A; Insulin stimulated MAP2 kinase; MAP kinase 1; MAP kinase 2; MAP kinase isoform p42; MAP kinase isoform p44; MAPK 1; MAPK 2; MAPK1; MAPK2; MGC20180; Microtubule associated protein 2 kinase; Mitogen activated protein kinase 1; Mitogen activated protein kinase 1; Mitogen activated protein kinase 2; Mitogen-activated protein kinase 1; Mitogen-activated protein kinase 2; MK01_MOUSE; p38; p40; p41; p41mapk; p42 MAPK; p42-MAPK; p42MAPK; p42MAPK; p44 ERK1; p44 MAPK; p44ERK1; p44ERK1; p44MAPK; p44MAPK; PRKM 1; PRKM 1; PRKM 2; PRKM 2; PRKM1; PRKM2; Protein kinase mitogen activated 1; Protein kinase mitogen activated 1; Protein kinase mitogen activated 2; Protein kinase mitogen activated 2; Protein tyrosine kinas. |
| Application Dilution | |
| Flow-Cyt | 1ug/Test |
| ICC/IF | 1:50-100 |